Gallery
- PM Modi visit USAOnly the mirror in my washroom and phone gallery see the crazy me : Sara KhanKarnataka rain fury: Photos of flooded streets, uprooted treesCannes 2022: Deepika Padukone stuns at the French Riviera in Sabyasachi outfitRanbir Kapoor And Alia Bhatt's Wedding Pics - Sealed With A KissOscars 2022: Every Academy Award WinnerShane Warne (1969-2022): Australian cricket legend's life in picturesPhotos: What Russia's invasion of Ukraine looks like on the groundLata Mangeshkar (1929-2022): A pictorial tribute to the 'Nightingale of India'PM Modi unveils 216-feet tall Statue of Equality in Hyderabad (PHOTOS)
India Open Competition in Shotgun, organised by the National Rifle Association of India (N
- Hockey India names Amir Ali-led 20-man team for Junior Asia Cup
- Harmanpreet Singh named FIH Player of the Year, PR Sreejesh gets best goalkeeper award
- World Boxing medallist Gaurav Bidhuri to flag off 'Delhi Against Drugs' movement on Nov 17
- U23 World Wrestling Championship: Chirag Chikkara wins gold as India end campaign with nine medals
- FIFA president Infantino confirms at least 9 African teams for the 2026 World Cup
Remdesivir production adequate, export ban precautionary: Amit Shah Last Updated : 19 Apr 2021 10:47:36 AM IST Union Home Minister Amit Shah has said that the production of the life saving drug Remdesivir is 'adequate' and as a precautionary measure its export has been banned.
Amit Shah said on Sunday, "The production of Remdisivir is adequate. We have banned export as precautionary but in panic people are buying in bulk which is leading to a shortage.""I appeal to the people to buy it when only the doctor prescribes," he added.The response comes after many state governments,including Maharashtra have complained about the shortage of the injectionsIndia on Sunday reported 2,61,500 fresh Covid cases, the highest single-day spike ever, pushing the country's overall Covid tally to 1,47,88,109, according to the Health Ministry data.IANS New Delhi For Latest Updates Please-
Join us on
Follow us on
172.31.16.186